JP2008526816A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008526816A5 JP2008526816A5 JP2007549909A JP2007549909A JP2008526816A5 JP 2008526816 A5 JP2008526816 A5 JP 2008526816A5 JP 2007549909 A JP2007549909 A JP 2007549909A JP 2007549909 A JP2007549909 A JP 2007549909A JP 2008526816 A5 JP2008526816 A5 JP 2008526816A5
- Authority
- JP
- Japan
- Prior art keywords
- administered
- drug
- reperfusion
- period
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims 9
- 229940079593 drugs Drugs 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 208000001953 Hypotension Diseases 0.000 claims 3
- 125000004122 cyclic group Chemical group 0.000 claims 3
- 206010002329 Aneurysm Diseases 0.000 claims 2
- 210000001367 Arteries Anatomy 0.000 claims 2
- 230000017531 blood circulation Effects 0.000 claims 2
- 230000000747 cardiac effect Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 206010000891 Acute myocardial infarction Diseases 0.000 claims 1
- 206010002383 Angina pectoris Diseases 0.000 claims 1
- 210000004204 Blood Vessels Anatomy 0.000 claims 1
- 208000005189 Embolism Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 208000003067 Myocardial Ischemia Diseases 0.000 claims 1
- 231100000614 Poison Toxicity 0.000 claims 1
- 206010040070 Septic shock Diseases 0.000 claims 1
- 208000001435 Thromboembolism Diseases 0.000 claims 1
- 208000007814 Unstable Angina Diseases 0.000 claims 1
- 206010047163 Vasospasm Diseases 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 230000003257 anti-anginal Effects 0.000 claims 1
- 230000002421 anti-septic Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000007887 coronary angioplasty Methods 0.000 claims 1
- 201000009910 diseases by infectious agent Diseases 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000003480 fibrinolytic Effects 0.000 claims 1
- 239000003527 fibrinolytic agent Substances 0.000 claims 1
- 201000010238 heart disease Diseases 0.000 claims 1
- 230000004217 heart function Effects 0.000 claims 1
- 230000036543 hypotension Effects 0.000 claims 1
- 238000001361 intraarterial administration Methods 0.000 claims 1
- 238000010253 intravenous injection Methods 0.000 claims 1
- 230000000302 ischemic Effects 0.000 claims 1
- 230000003902 lesions Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000002107 myocardial Effects 0.000 claims 1
- 239000002574 poison Substances 0.000 claims 1
- 238000011084 recovery Methods 0.000 claims 1
- 230000036303 septic shock Effects 0.000 claims 1
- 230000002588 toxic Effects 0.000 claims 1
- 231100000331 toxic Toxicity 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05000357 | 2005-01-10 | ||
| PCT/EP2006/050140 WO2006072639A1 (fr) | 2005-01-10 | 2006-01-10 | Utilisation d’un undecapeptide cyclique pour la preparation d’un médicament administrable lors de situations ischemiques myocardiques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008526816A JP2008526816A (ja) | 2008-07-24 |
| JP2008526816A5 true JP2008526816A5 (pt-PT) | 2009-02-05 |
Family
ID=34933239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007549909A Pending JP2008526816A (ja) | 2005-01-10 | 2006-01-10 | 心筋虚血状態の間の投与のための薬剤の製造のための環状ウンデカペプチドの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8889629B2 (pt-PT) |
| EP (1) | EP1853296B1 (pt-PT) |
| JP (1) | JP2008526816A (pt-PT) |
| DK (1) | DK1853296T5 (pt-PT) |
| ES (1) | ES2387682T3 (pt-PT) |
| PL (1) | PL1853296T3 (pt-PT) |
| PT (1) | PT1853296E (pt-PT) |
| SI (1) | SI1853296T1 (pt-PT) |
| WO (1) | WO2006072639A1 (pt-PT) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2023948A1 (en) * | 2006-05-04 | 2009-02-18 | Michel Ovize | Use of cyclosporin a or melle4-cyclosporin for the treatment of acute myocardial infarction |
| WO2009098533A1 (en) * | 2008-02-08 | 2009-08-13 | Debiopharm Sa | Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy |
| WO2011141891A1 (en) | 2010-05-12 | 2011-11-17 | Debio Recherche Pharmaceutique S.A. | Use of cycloundecadepsipeptide compounds |
| GB201217560D0 (en) | 2012-10-02 | 2012-11-14 | Mitopharm Ltd | Novel cyclic depsipeptide compounds and their uses |
| WO2014150388A1 (en) * | 2013-03-15 | 2014-09-25 | Boston Scientific Scimed, Inc. | System for controlling a tissue-stapling operation with pressurized fluid |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999019471A1 (en) * | 1997-10-16 | 1999-04-22 | Board Of Regents, The University Of Texas System | Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| EP1056729B1 (en) * | 1998-02-27 | 2004-12-29 | Pfizer Products Inc. | N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia |
| JP4350898B2 (ja) * | 1998-07-01 | 2009-10-21 | デビオファーム・ソシエテ・アノニム | 活性の特徴が改善された新規のシクロスポリン |
| ES2267492T3 (es) * | 1999-02-05 | 2007-03-16 | Debiopharm S.A. | Derivados de ciclosporina y procedimiento de preparacion de dichos derivados. |
-
2006
- 2006-01-10 ES ES06704161T patent/ES2387682T3/es active Active
- 2006-01-10 SI SI200631402T patent/SI1853296T1/sl unknown
- 2006-01-10 EP EP06704161A patent/EP1853296B1/fr active Active
- 2006-01-10 PL PL06704161T patent/PL1853296T3/pl unknown
- 2006-01-10 JP JP2007549909A patent/JP2008526816A/ja active Pending
- 2006-01-10 WO PCT/EP2006/050140 patent/WO2006072639A1/fr active Application Filing
- 2006-01-10 US US11/794,245 patent/US8889629B2/en not_active Expired - Fee Related
- 2006-01-10 DK DK06704161.6T patent/DK1853296T5/da active
- 2006-01-10 PT PT06704161T patent/PT1853296E/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2201784C (en) | Method and formulation of stimulating nitric oxide synthesis | |
| JP2010523714A5 (pt-PT) | ||
| JP2015057436A5 (pt-PT) | ||
| JP2008526816A5 (pt-PT) | ||
| CN101506151A (zh) | 改善药物中具有脒官能团的活性物质的生物利用度 | |
| JP2018509419A5 (pt-PT) | ||
| WO1996038173A1 (fr) | Inhibiteur de l'oedeme cerebral | |
| ES2704229T3 (es) | Agonistas selectivos del receptor AT2 para su uso en el tratamiento de la caquexia | |
| AU2010277725B2 (en) | Otamixaban for treatment of elderly and renal impaired non-ST elevation myocardial infarction patients | |
| CN1352944A (zh) | 吉西他滨溶液制剂 | |
| JP2023551503A (ja) | 抗血栓剤としてのシクロスポリン類似体の使用 | |
| CA2482687A1 (en) | Treatment of mesothelioma | |
| CN104703602B (zh) | 1‑金刚烷乙氧基‑3‑吗啉基‑2‑丙醇或其药学上可接受的盐的药物组合物用于治疗心血管病变 | |
| KR20160080116A (ko) | 약학 물질로 사용되는 아미노산 유도체 | |
| WO2015178683A1 (ko) | p-당단백질의 저해제 및 p-당단백질의 기질 약물을 포함하는 약제학적 조성물 | |
| JPH03505447A (ja) | アミオダロンと、ニトロ誘導体、特にイソソルビト二硝酸と、必要に応じてさらにβ―遮断薬とを含む心臓保護効果のある医薬組成物 | |
| JP2006503049A5 (pt-PT) | ||
| HU207455B (en) | Method for producing pharmaceutical preparations suitable for treating postischemical heart-troubles containing captoprile and in given case thrombolitic agent | |
| CN1019545B (zh) | 制备用于治疗心律不齐的含有喹啉衍生物的组合物的方法 | |
| JP2004231557A (ja) | エピネフリン含有抗腫瘍剤 | |
| JP2022151414A (ja) | 虚血性心臓疾患治療薬 | |
| AU2023207157A1 (en) | Treatment for congestive heart failure | |
| JP2004155661A (ja) | 突然死予防剤 | |
| RU2004108117A (ru) | Нептидиларгинали и способы лечения синдрома диссеминированного внутрисосудистого свертывания | |
| Civera et al. | Acute coronary syndrome presenting as syncope |